Patanjali Foods Ltd, which is part of Baba Ramdev-led Patanjali Group, on Tuesday said the company's business operations and financial performance will not be impacted because of the Supreme Court's observation on ads related to ayurvedic medicines sold by a promoter group firm.
In a regulatory filing, Patanjali Foods said the 'observations of Supreme Court of India do not relate to the company which is an independent listed entity and operates in the space of edible oil and food FMCG products only.'
-
Gold Price Dips Ahead Of Diwali: Can It Go Lower On Dhanteras? What To Expect -
India's Market Leaders To Decode The New Samvat At NDTV Profit Ignite In Mumbai On Oct 28 -
NDTV Profit IGNITE Diwali 2026: Top Market Veterans Decode Wealth Creation -
The Week Ahead: Earnings Season, Fed Policy Verdict And Crude Oil In Focus -
Silver Is Now Down From Rs 4.2 Lakh To Rs 1.9 Lakh: Where It Goes From Here -
NDTV Ignite, The Trillion-Dollar Trajectory: India's Road to 2030
'The observations do not have any beating on the regular business operations or the financial performance of Patanjali Foods,' the company said.
Patanjali Group has nearly 74% stake in Patanjali Foods.
Out of 73.82% promoter stake, Patanjali Ayurved has 32.37% stake.
Earlier in the day, the Supreme Court said the entire country has been 'taken for a ride', as it restrained till further orders Patanjali Ayurved from advertising or branding products meant for treating diseases.
Issuing notices to Patanjali Ayurved and Managing Director Acharya Balkrishna, the apex court also asked why contempt proceedings should not be initiated against them for prima facie violating the firm's undertaking given in the court about advertising of its products and their medicinal efficacy.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.